BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15613723)

  • 41. Rapid evolution in the immunochemical findings of a gamma heavy chain disease.
    Pontet F; Gué X; Dosquet C; Caen J; Rousselet F
    Clin Chem; 1988 Feb; 34(2):439-43. PubMed ID: 3124986
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
    Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
    Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma.
    Butch AW; Badros A; Desikan KR; Munshi NC
    Bone Marrow Transplant; 2001 Mar; 27(6):663-6. PubMed ID: 11319600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A unique case of γ-heavy chain deposition disease characterized by concomitant deposition of γ2 and γ4 subclasses.
    Yin G; Wu Y; Zeng CH; Chen HP; Liu ZH
    Intern Med; 2014; 53(22):2615-8. PubMed ID: 25400185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A case of γ1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy.
    Oe Y; Nakaya I; Yahata M; Sakuma T; Sato H; Soma J
    Intern Med; 2010; 49(14):1411-5. PubMed ID: 20647658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypercalcemia and reversible renal failure in heavy-chain disease.
    Eisner SB; Mitnick PD
    South Med J; 1986 Apr; 79(4):507-9. PubMed ID: 3085235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alpha heavy chain disease: report of two cases.
    Geraci L; Merlini G; Spadano A; Di Matteo S; Torlontano G; Ascari E
    Haematologica; 1985; 70(5):431-6. PubMed ID: 3937780
    [No Abstract]   [Full Text] [Related]  

  • 48. Discovery of a gamma heavy chain disease in a patient followed-up for a lymphoplasma cell proliferative disorder.
    Humeau C; Monjanel H; Schellenberg F
    Ann Biol Clin (Paris); 2016 Jun; 74(3):338-40. PubMed ID: 27237805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Heavy chain disease, gamma type. Description of a variant case].
    Triolo L; Mian G; Magris D; Novello E; Lupinc V; D'Agnolo B
    Minerva Med; 1979 Apr; 70(19):1361-8. PubMed ID: 109791
    [No Abstract]   [Full Text] [Related]  

  • 50. Chronic arthritis and gamma heavy chain disease: coincidence or pathogenic link?
    Husby G; Blichfeldt P; Brinch L; Brandtzaeg P; Mellbye OJ; Sletten K; Stenstad T
    Scand J Rheumatol; 1998; 27(4):257-64. PubMed ID: 9751465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Free fragments of gamma chain in the urine. A possible source of confusion with gamma heavy-chain disease.
    Charles EZ; Valdes AJ
    Am J Clin Pathol; 1994 Apr; 101(4):462-4. PubMed ID: 8160637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Alpha chain disease (report of the 1st case in Yugoslavia)].
    Ramljak A; Abinun A; Tanacković F; Radosavljević R; Pikula B
    Med Arh; 1977; 31(1):29-36. PubMed ID: 405535
    [No Abstract]   [Full Text] [Related]  

  • 53. Heavy chain diseases.
    Wahner-Roedler DL; Kyle RA
    Best Pract Res Clin Haematol; 2005; 18(4):729-46. PubMed ID: 16026747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gamma heavy chain disease studied by two-dimensional electrophoresis and immuno-blotting techniques.
    Blangarin P; Deviller P; Kindbeiter K; Madjar JJ
    Clin Chem; 1984 Dec; 30(12 Pt 1):2021-5. PubMed ID: 6437695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gamma-chain heavy-chain disease with primary thyroid plasmacytoma.
    Ottó S; Péter I; Végh S; Juhos E; Besznyák I
    Arch Pathol Lab Med; 1986 Oct; 110(10):893-6. PubMed ID: 3094476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gamma heavy chain disease. Where the heavy chains arise.
    Pastuszak WT; Scholes JV; Kosciol C; Cartun R
    Am J Clin Pathol; 1983 Apr; 79(4):520-1. PubMed ID: 6404156
    [No Abstract]   [Full Text] [Related]  

  • 57. Gamma heavy chain disease screening showing a discrepancy between electrophoretic and nephelometric determinations of serum gamma globulin concentration.
    Takatani T; Morita K; Takaoka N; Tatsumi M; Okuno Y; Masutani T; Murakawa K; Fukui A; Tsukaguchi N; Okamoto Y
    Ann Clin Biochem; 2002 Sep; 39(Pt 5):531-3. PubMed ID: 12227865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gamma heavy chain disease--presenting as pancytopenia and splenomegaly.
    Baker AS; Lankford P; Krantz SB; Buchanan RD
    South Med J; 1977 Apr; 70(4):495-7. PubMed ID: 403613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. N-ras oncogene activation in a patient with gamma heavy chain disease.
    Moskovits T; Jacobson DR; Buxbaum J
    Am J Hematol; 1992 Dec; 41(4):302-3. PubMed ID: 1288299
    [No Abstract]   [Full Text] [Related]  

  • 60. [Gamma 1 heavy chain disease with immune vasculitis and rheumatoid arthritis].
    Stühlinger W; Berek K; Lapin A; Jaschke E; Pastner D
    Klin Wochenschr; 1987 Apr; 65(8):359-68. PubMed ID: 3108571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.